Article
Droplet digital PCR for genetic mutations monitoring predicts relapse risk in pediatric acute myeloid leukemia.
International journal of hematology - 1 Nov 2022
Chen Xiaoyan, Liu Lipeng, Zhang Aoli, Yi Meihui, Lan Yang, Zheng Zhongzheng, Zhang Luyang, Liu Xiaoming, Chang Lixian, Zou Yao, Ruan Min, Zhu Xiaofan
Abstract excerpt
Multiparameter flow cytometry (MFC)-based minimal residual disease has been a poor predictor of prognosis in children with acute myeloid leukemia (AML). This study aimed to evaluate the incremental value of serial monitoring by droplet digital PCR (ddPCR) in forecasting the outcome of AML. Twenty-four children with AML were enrolled and the relapse-free survival (RFS) rate was estimated using the Kaplan-Meier...
Topics
Join the communities discussing this publication.
